Skip to main content
Clinical Trials/NCT03405753
NCT03405753CompletedNot Applicable

Effects of Aronia Berry on Oxidative Stress, Cholesterol, Blood Pressure and Semen Quality

Odense University Hospital1 site in 1 country109 target enrollmentStarted: February 1, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
109
Locations
1
Primary Endpoint
Cholesterol

Study Overview

Brief Summary

Intervention cross-over study during which participants receive standardized amounts of aronia berry tablets or placebo for three months, then wash out for three months, then aronia tablets or placebo for three months. The potential health effects are investigated. Following parameters are measured before and after each period of tablet intake: 1) Blood pressure, 2) Lipid fractions, 3) Testosterone, 4) Phase II markers, 5) HbA1c, 6) HSCRP, 7) F2-isoprostanes, and 8) semen quality.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Prevention
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
25 Years to 65 Years (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Healthy men with total cholesterol between 5 and 7 mmol/L, who do not take medication

Exclusion Criteria

  • •Chronic diseases and intake of medication or antioxidants

Arms & Interventions

Aroia

Active Comparator

Intervention: Aronia, washout and then placebo (Dietary Supplement)

Aroia

Active Comparator

Intervention: Placebo, washout and then aronia (Dietary Supplement)

Placebo

Placebo Comparator

Intervention: Aronia, washout and then placebo (Dietary Supplement)

Placebo

Placebo Comparator

Intervention: Placebo, washout and then aronia (Dietary Supplement)

Outcomes

Primary Outcomes

Cholesterol

Time Frame: 9 months

HDL, LDL and total cholesterol in mmol/L

Secondary Outcomes

  • Phase II enzyme activity(9 months)
  • Semen quality(9 months)
  • Blood pressure(9 months)
  • Isoprostanes(9 months)
  • High Sensitivity C reactive protein(9 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jens Fedder

Professor

Odense University Hospital

Study Sites (1)

Loading locations...

Similar Trials